2027
2027 funding pages collect matching grants, scholarships, benefits, fellowships, and other programs from the FindMyMoney.App directory. Use this page to compare current opportunities, then verify deadlines and eligibility on the official source before applying.
Research Explorer Ruhr 2027 in Germany: Two-Week Funded Research Program (2026 Cycle Closed)
Historical reference for the closed Research Explorer Ruhr 2026 cycle. Research Academy has announced the next visit for 13–27 June 2027, with applications expected to begin in early January, but has not published the 2027 closing date or application form.
RFA-CA-27-006: NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
A federal clinical-research cooperative agreement for US institutions to serve as NCORP research hubs that run cancer prevention, treatment, symptom-management, and care-delivery trials in community settings.
RFA-CA-27-021: Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)
The National Cancer Institute's RFA-CA-27-021 supports continued operations and improvement of existing, widely adopted informatics tools and resources for cancer research, with awards capped at $600,000 in direct costs per year for up to five years.
RFA-DA-26-034: Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on the Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic Opioids
NIH Trans-NIH RFA supports basic and applied research on acute exposure effects and delayed effects of ultra-potent synthetic opioids, with recurring R01 due dates in 2026 and 2027.
RFA-ES-25-002: Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
The National Institute of Environmental Health Sciences invites U.S. applicants to propose Environmental Health Sciences Core Centers through the P30 mechanism. The next listed application due date is April 20, 2027.
RFA-HD-27-012: Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
A limited-competition NIH renewal for existing NICHD IDDRCs, this NOFO funds interdisciplinary P50 centers advancing translational, biomarker, and real-world research for intellectual and developmental disabilities.
RFA-HL-26-019: Catalyze Product Definition - Medical Device Prototype Design/Testing and Disease Target Identification and Assay Development (R61/R33; Clinical Trial Not Allowed)
NIH NHLBI Catalyze Product Definition NOFO for early-stage device, diagnostic, and research-tool development in heart, lung, blood, and sleep diseases. The next new-application due date is October 21, 2026.
RFA-HL-27-004: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
NIH’s NHLBI RFA-HL-27-004 is a limited-competition R03 small grant opportunity to help current and recently completed NHLBI K01/K08/K23/K25 awardees advance toward independent funding through a short, NIH-funded pilot- to proof-of-concept scale project.
RMIT Welcome and Sam & Nina Narodowski Asylum Seeker Scholarships 2027: Tuition, Fees and Living Support
RMIT's open 2027 scholarships support eligible people seeking asylum in Australia with program tuition fees and SSAF, plus study or living allowances for approved vocational and undergraduate study in Melbourne.
Robert Wood Johnson Foundation Health Policy Fellows 2027–2028: $175,000 Fellowship and Washington, D.C. Policy Placement
The Robert Wood Johnson Foundation Health Policy Fellows program offers up to eight mid-career health professionals a $175,000 fellowship over 12–24 months, full-time federal policy experience in Washington, D.C., and up to $20,000 in relocation and approved housing support.